Stevanato Group (STVN) Stock Price, News & Analysis

Company Overview

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Key Stats

• Today's Range: €22.87 to €24.94
• 50-Day Range: €20.74 to €24.77
• 52-Week Range: €16.56 to €25.75
• Volume: 255,700 shs
• Average Volume: 338,581 shs
• Market Capitalization: $7.48 billion
• P/E Ratio: 48.45
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

STVN Stock Analysis - Frequently Asked Questions

How have STVN shares performed this year?

Stevanato Group's stock was trading at €21.79 at the beginning of 2025. Since then, STVN stock has increased by 13.4% and is now trading at €24.71.
View the best growth stocks for 2025 here.

How were Stevanato Group's earnings last quarter?

Stevanato Group S.p.A. (NYSE:STVN) issued its quarterly earnings results on Thursday, March, 6th. The company reported $0.20 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.20. The company earned $352.68 million during the quarter, compared to analyst estimates of $346.26 million. Stevanato Group had a net margin of 11.14% and a trailing twelve-month return on equity of 10.00%.
Read the conference call transcript.

When did Stevanato Group IPO?

Stevanato Group (STVN) raised $720 million in an initial public offering on Friday, July 16th 2021. The company issued 32,000,000 shares at $21.00-$24.00 per share.

Who are Stevanato Group's major shareholders?

Stevanato Group's top institutional shareholders include Conestoga Capital Advisors LLC (2.70%), T. Rowe Price Investment Management Inc. (1.24%), TimesSquare Capital Management LLC (1.11%) and Jennison Associates LLC (0.39%).

How do I buy shares of Stevanato Group?

Shares of STVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Stevanato Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Stevanato Group investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Fortinet (FTNT), Antero Resources (AR), CrowdStrike (CRWD), Walt Disney (DIS) and ON Semiconductor (ON).

Company Calendar

• Last Earnings: 3/06/2025
• Record date for 7/17 Dividend: 6/05/2025
• Ex-Dividend for 7/17 Dividend: 6/05/2025
• Today: 6/25/2025
• Dividend Payable: 7/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:STVN
• CIK: 1849853
• Web: www.stevanatogroup.com
• Phone: 39049931811
• Fax: N/A
• Employees: 5,521
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): €0.51
• Trailing P/E Ratio: 48.45
• Forward P/E Ratio: 49.42
• P/E Growth: 2.24
• Net Income: $127.45 million
• Net Margins: 11.14%
• Pretax Margin: 15.12%
• Return on Equity: 10.00%
• Return on Assets: 6.03%

Debt

• Debt-to-Equity Ratio: 0.22
• Current Ratio: 1.83
• Quick Ratio: 1.26

Sales & Book Value

• Annual Sales: $1.19 billion
• Price / Sales: 6.26
• Cash Flow: €0.80 per share
• Price / Cash Flow: 31.05
• Book Value: €5.02 per share
• Price / Book: 4.92

Miscellaneous

• Outstanding Shares: 302,840,000
• Free Float: N/A
• Market Cap: $7.48 billion
• Optionable: Optionable
• Beta: 0.53